Escalon Medical Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company's revenues, net was $3,151,651 against $2,724,740 a year ago. Income from operations was $112,308 against loss from operations of $294,865 a year ago. Net income from continuing operations was $112,354 or $0.01 per basic and diluted share against net loss from continuing operations of $283,761 or $0.04 per basic and diluted share a year ago. Net income was $86,084 or $0.01 per basic and diluted share against net loss of $285,864 or $0.04 per basic and diluted share a year ago.

For the nine months, the company's revenues, net was $9,360,219 against $8,635,078 a year ago. Income from operations was $60,719 against loss from operations of $781,847 a year ago. Net income from continuing operations was $68,426 or $0.01 per basic and diluted share against net loss from continuing operations of $781,424 or $0.10 per basic and diluted share a year ago. Net income was $9,223 against net income of $3,274,082 or $0.44 per basic and diluted share a year ago, which includes a net gain of $4.1 million related to the sale of Drew and related debt settlement.